MetaCap

Veraxa Biotech Insider Trades

NASDAQ: VRXAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.04+0.01 (+0.97%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
5 · $125.33K
Sales
0 · $0
Shares bought / sold
95.00K / 0
Net activity
Net buying $125,333

Veraxa Biotech insider activity

Over the last 12 months, Veraxa Biotech insiders reported 5 transactions on SEC Form 4: 5 open-market purchases and 0 sales. Insiders bought $125,333 and sold $0 worth of stock, for net insider buying of $125,333. The most recent filing shows Gruninger Marc (Director) buying 9,133 shares at $1.00 on Oct 28, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put VRXA's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

VRXA insider transactions

Veraxa Biotech insider transactions
DateInsiderTypeSharesValueFiling
Oct 28, 2026Gruninger MarcDirectorBuy9,133$9.13KForm 4
Oct 27, 2026Gruninger MarcDirectorBuy867$849.66Form 4
Oct 20, 2026Ziegler Christoph SamuelDirectorBuy30,000$32.70KForm 4
Aug 27, 2026Antz Christoph RudigerChief Executive OfficerBuy5,000$7.65KForm 4
Aug 27, 2026Baumann Oliver RolfDirectorBuy50,000$75.00KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related